載入...

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance

BACKGROUND: Tuberculosis (TB) is the world’s leading infectious cause of death. Extrapulmonary TB accounts for 15% of TB cases, but the proportion is increasing, and over half a million people were newly diagnosed with rifampicin‐resistant TB in 2016. Xpert(®) MTB/RIF (Xpert) is a World Health Organ...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cochrane Database Syst Rev
Main Authors: Kohli, Mikashmi, Schiller, Ian, Dendukuri, Nandini, Dheda, Keertan, Denkinger, Claudia M, Schumacher, Samuel G, Steingart, Karen R
格式: Artigo
語言:Inglês
出版: John Wiley & Sons, Ltd 2018
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513199/
https://ncbi.nlm.nih.gov/pubmed/30148542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012768.pub2
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!